Editorial: Multisystem inflammatory syndrome observed post-COVID-19: the role of natural products, medicinal plants and nutrients and the use of prediction tools supporting traditional forms of diagnosis
Saved in:
Main Authors: | Anthony Booker, Ioannis Zabetakis, Nicole Elisabeth Teusch, Andrew Dalby, Thomas Hartung, Angela E. Peter |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1539793/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Similarities and Differences between Coronavirus Disease 2019-related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease in Indian Patients
by: Utkarsh Singh, et al.
Published: (2024-05-01) -
Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
by: Swarnalata Das, et al.
Published: (2024-01-01) -
Long-COVID symptoms after multisystem inflammatory syndrome in children during different pandemic waves
by: Katarzyna Ptak, et al.
Published: (2024-10-01) -
Extracorporeal membrane therapy in a case of ruptured abscess on the mitroaortic intervalvular fibrosa associated to multisystem inflammatory syndrome: a case report
by: Lina P. Montaña-Jimenez, et al.
Published: (2025-01-01) -
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, clinical characteristics: A multi-center observational study from Jordan
by: Marwan Shalabi, et al.
Published: (2025-06-01)